GALERA THERAPEUTICS INC
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GRTX and buy or sell other stocks, ETFs, and their options commission-free!About GRTX
Galera Therapeutics, Inc. is a clinical stage biotechnology company, which engages in developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. It is also involved in the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis, and cancer.
CEOJohn Mel Sorensen
CEOJohn Mel Sorensen
Employees3
Employees3
HeadquartersMalvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded2009
Founded2009
Employees3
Employees3
GRTX Key Statistics
Market cap1.74M
Market cap1.74M
Price-Earnings ratio-0.11
Price-Earnings ratio-0.11
Dividend yield—
Dividend yield—
Average volume338.12K
Average volume338.12K
High today—
High today—
Low today—
Low today—
Open price$0.018
Open price$0.018
Volume0.00
Volume0.00
52 Week high$0.0605
52 Week high$0.0605
52 Week low$0.0151
52 Week low$0.0151
GRTX News
TipRanks 1d
Biossil to acquire Galera’s dismutase mimetics portfolio for up to $105MGalera Therapeutics (GRTX) entered into an asset purchase agreement with Toronto-based biotech Biossil for the acquisition of Galera’s dismutase mimetics portfo...
People also own
Based on the portfolios of people who own GRTX. This list is generated using Robinhood data, and it’s not a recommendation.